Characteristics | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Hazard Ratio | CI 95 | P Value | Hazard Ratio | CI 95 | P Value | |
1-year DFS | ||||||
risk score of 25-lncRNA signature | 2.38 | 1.88–3.01 | < 0.001 | 2 | 1.48–2.71 | < 0.001 |
TNM Stages | 1.96 | 1.55–2.47 | < 0.001 | 1.28 | 0.94–1.75 | 0.124 |
Vascular Invasion | 1.88 | 1.35–2.61 | < 0.001 | 1.66 | 1.12–2.45 | 0.011 |
AFP | 2.52 | 1.56–4.07 | < 0.001 | 2.23 | 1.34–3.74 | 0.002 |
Cirrhosis | 1.11 | 0.65–1.9 | 0.709 | |||
Gender | 1.17 | 0.78–1.77 | 0.444 | |||
Age | 0.77 | 0.49–1.22 | 0.269 | |||
Race | 1.15 | 0.83–1.59 | 0.396 | |||
2-year DFS | ||||||
risk score of 25-lncRNA signature | 2.19 | 1.8–2.66 | < 0.001 | 1.92 | 1.48–2.49 | < 0.001 |
TNM Stages | 1.96 | 1.61–2.39 | < 0.001 | 1.46 | 1.12–1.89 | 0.005 |
Vascular Invasion | 1.8 | 1.36–2.38 | < 0.001 | 1.5 | 1.05–2.12 | 0.024 |
AFP | 2.03 | 1.37–2.99 | < 0.001 | 1.77 | 1.16–2.71 | 0.008 |
Cirrhosis | 1.25 | 0.81–1.93 | 0.305 | |||
Gender | 1.21 | 0.86–1.71 | 0.27 | |||
Age | 0.91 | 0.6–1.36 | 0.635 | |||
Race | 0.84 | 0.62–1.12 | 0.229 |